Hair Loss Reported With GLP-1 Drugs: A New Safety Signal to Monitor
Case series and review of hair loss associated with GLP-1 receptor agonists identifies a previously underrecognized side effect that may be related to rapid weight loss or direct drug effects.
Quick Facts
What This Study Found
Case series and review of hair loss associated with GLP-1 receptor agonists identifies a previously underrecognized side effect that may be related to rapid weight loss or direct drug effects.
Key Numbers
Systematic review of FAERS dermatological adverse events and clinical literature on GLP-1 RA-associated hair loss.
How They Did This
In publication.
Why This Research Matters
Relevant to peptide therapeutics.
The Bigger Picture
Advances peptide therapeutic knowledge.
What This Study Doesn't Tell Us
In publication.
Questions This Raises
- ?Long-term implications?
- ?Comparison to evidence?
- ?Next research?
Trust & Context
- Key Stat:
- Key finding Case series and review of hair loss associated with GLP-1 receptor agonists identifies a previously
- Evidence Grade:
- Based on study design.
- Study Age:
- Published in 2025.
- Original Title:
- Hair Loss Associated With Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist Use: A Systematic Review.
- Published In:
- Cureus, 17(9), e92454 (2025)
- Authors:
- Alsuwailem, Omar A, Alanazi, Rawan, Almutairi, Hessa M, Asiree, Rayan H, Almutairi, Wasan, Almutairi, Taghreed M, Zamandar, Alia, Alkhames, Saleh
- Database ID:
- RPEP-09909
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
What does this mean?
Case series and review of hair loss associated with GLP-1 receptor agonists identifies a previously underrecognized side effect that may be related to rapid weight loss or direct drug effects.
How reliable?
Consult publication.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-09909APA
Alsuwailem, Omar A; Alanazi, Rawan; Almutairi, Hessa M; Asiree, Rayan H; Almutairi, Wasan; Almutairi, Taghreed M; Zamandar, Alia; Alkhames, Saleh. (2025). Hair Loss Associated With Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist Use: A Systematic Review.. Cureus, 17(9), e92454. https://doi.org/10.7759/cureus.92454
MLA
Alsuwailem, Omar A, et al. "Hair Loss Associated With Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist Use: A Systematic Review.." Cureus, 2025. https://doi.org/10.7759/cureus.92454
RethinkPeptides
RethinkPeptides Research Database. "Hair Loss Associated With Glucagon-Like Peptide-1 (GLP-1) Re..." RPEP-09909. Retrieved from https://rethinkpeptides.com/research/alsuwailem-2025-hair-loss-associated-with
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.